Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Risk of Invokana Side Effects May Outweigh Benefits: Report May 15, 2015 Irvin Jackson Add Your Comments A new drug safety report suggests that the high rate of infections and other side effects of Invokana may tip the balance in the risk-benefit analysis for the diabetes drug. In a QuarterWatch report (PDF) issued on May 6, the Institute for Safe Medication Practices (ISMP) looked at the safety and efficacy of the Johnson & Johnson diabetes drug, which has only been on the market for about two years. Invokana was released amid concerns about side effects associated with a variety of other diabetes drugs, but appears to be linked to health risks of its own, which raise questions about whether the drug’s risks may outweigh the benefits for diabetics. Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA approved Invokana (canagliflozin) in March 2013, as the first in a new class of diabetes medications that inhibit a particular function of the kidney, allowing an increased amount of sugar to be excreted in the urine. Introduced by Johnson & Johnson’s Janssen subsidiary, the drug came in the wake of heart attack concerns over the drug Avandia, bladder cancer concerns involving the diabetes drug Actos, and the beginning of pancreatic cancer concerns involving the diabetes drugs Byetta, Januvia, Janumet and Victoza. Following two years of adverse event data, the ISMP report raises concerns over Invokana side effects and the clinical trials used to approve the medication for the market. Adverse Events Involving Invokana Problems During the first year after Invokana was approved, ISMP found 457 serious adverse event reports submitted to federal drug regulators, which typically only account for a small portion of the total problems associated with prescription medications on the market. Many of the reported Invokana problems involved kidney failure, kidney impairment or problems with kidney stones, urinary tract infections, dehydration, hypersensitivity and abnormal weight loss. Janssen officials reportedly told ISMP investigators that most of those injuries are known risks that are warned about on the drug’s label, with the exception of kidney stones. However, the ISMP report questions whether the benefits provided by Invokana justify those risks. “At the time of FDA approval, canagliflozin had not been tested in a sufficient number of patients for a long enough period of time to answer that question,” the report states. “In the face of that uncertainty about benefit was increasing evidence that canagliflozin is associated with adverse effects in appropriate clinical use.” Clinical trials for the drug found that urogenital infections, mainly fungal, were the most frequent side effect of Invokana, with a full 14% of women and nearly 4% of men who took the drug developing fungal infections at rates as high as six times that of non-Invokana users with similar kidney and health profiles. Looking at reports to the FDA’s adverse event reporting system, the researchers found that Invokana received more serious adverse event reports than 92% of the other drugs regularly monitored. The ISMP report found that at the cost of those risks came very few benefits. According to the report, the Invokana clinical trials showed that the drug typically lowered levels of glycated hemoglobin (HbA1c), a primary type 2 diabetes blood sugar measurement, by about only one percent. It also caused weight loss of a mean of five to six pounds in users. “While Janssen noted that the drug had now been tested in more than 10,000 patients, the data were still of insufficient duration to establish whether the drug had a measurable clinical benefit on the complications of Type 2 diabetes,” the report concludes. “The current data are also insufficient to address unanswered questions raised in the FDA reviews about whether long-term use might result in a steady decline in kidney function, increased risk of bone fractures, or more cardiovascular events. By contrast, we observe clear evidence of harm to some patients in terms of hypersensitivity reactions and an array of renal adverse effects.” Tags: Diabetes, Diabetes Drug, Hypersensitivity, Infection, Invokana, Johnson & Johnson, Kidney Failure Image Credit: | More Invokana Lawsuit Stories Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022 Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021 Study Finds No Link Between Bone Fractures And Invokana, Similar Diabetes Drugs September 22, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024) Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)
Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022
Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)